Furthermore, adoptive transfer of tumor-primed FoxP1-deficient T cells enhanced survival in mouse models of ovarian cancer and sarcoma, relative to wild-type T cell transfer [103]. This evidence concerns the gene FOXP1 and ovarian cancer.